Home / News
Announcements, events and coverage of Vernus AI and the ReAIX platform.
Founder & CEO Jimmy Lin will give a keynote at the opening ceremony of the Seongnam Bio-Healthcare International Convention on October 29, on turning AI drug discovery into global biohealth business.
Read the story →
Selected from 2,000+ applications worldwide as one of three Taiwanese startups, Vernus AI will join Google DeepMind and Google Cloud experts in Mountain View.
Read the story →
Meet the team at Fiera Milano, October 6–8, at Booth 8F61 (AI & Tech Zone) and Booth 8F2 (Taiwan Pharma Pavilion), and see ReAIX Chem, Bio and Formulation in action.
Read the story →
Vernus AI joins AppWorks #33, the inaugural Google Project Hatcher × SparkLabs AI Global Expansion program, and the 2nd cohort of the TAI1 AI Accelerator.
Read the story →
Booth M434 at Taipei Nangang Exhibition Center, July 16–19: the ReAIX platform and our Siemens Simcenter STAR-CCM+ collaboration on CFD digital twins for scale-up.
Read the story →
At the BIO International Convention on June 24, Vernus AI presented ReAIX to pharma and biotech partners from North America, Europe and Asia-Pacific. Several discussions have moved to in-depth evaluation.
Read the story →
ReAIX was covered by PR Newswire, Commercial Times, Liberty Times, MoneyDJ and TTV Finance during COMPUTEX 2026 and NVIDIA GTC, alongside a quantum AI keynote by investor and partner Compal Electronics.
Read the story →
A USD 8.4 million seed round of cash, AI compute and quantum computing resources, from Compal Electronics, Orient EuroPharma (OEP), PharmaSTAR BioT Venture Capital and pharmaceutical experts.
Read the story →
Selected among the top 30 of more than 2,800 applicants in the National Development Council's Startup Bloom competition, in the Future Engine — Advanced Technology category.
Read the story →